CSPC PHARMACEUT.GR. ADR4 Financial Flexibility Index
CSPC PHARMACEUT.GR. ADR4 financial flexibility index. CSPC PHARMACEUT.GR. ADR4 (CVGU) has a Financial Flexibility Index of 0.67x as of December 2025. Free cash flow of €8.11 Billion (operating CF €5.83 Billion minus capex €2.28 Billion) represents 1% of total liabilities (€12.15 Billion). See CVGU free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CSPC PHARMACEUT.GR. ADR4 (2021–2025)
Financial flexibility index of CSPC PHARMACEUT.GR. ADR4 from 2021 to 2025. Historical Financial Flexibility Index trend for CSPC PHARMACEUT.GR. ADR4 across 5 annual periods. Check CSPC PHARMACEUT.GR. ADR4 earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CSPC PHARMACEUT.GR. ADR4 Financial Flexibility Index by Year (2021–2025)
CSPC PHARMACEUT.GR. ADR4 financial flexibility index by year from 2021 to 2025. Year-by-year free cash flow to debt coverage for CSPC PHARMACEUT.GR. ADR4. For the full cash flow conversion analysis, see CSPC PHARMACEUT.GR. ADR4 operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | €8.11 Billion | €5.83 Billion | €12.15 Billion | ▼ -2.6% |
| 2024 | 0.69x | €7.21 Billion | €4.53 Billion | €10.52 Billion | ▲ +27.2% |
| 2023 | 0.54x | €6.07 Billion | €4.18 Billion | €11.26 Billion | ▼ -47.3% |
| 2022 | 1.02x | €10.35 Billion | €7.63 Billion | €10.13 Billion | ▲ +26.5% |
| 2021 | 0.81x | €6.40 Billion | €4.64 Billion | €7.91 Billion | — |